Inflammatory arthritis in patients with COVID-19.


Journal

Translational research : the journal of laboratory and clinical medicine
ISSN: 1878-1810
Titre abrégé: Transl Res
Pays: United States
ID NLM: 101280339

Informations de publication

Date de publication:
06 2021
Historique:
received: 30 10 2020
revised: 17 02 2021
accepted: 19 02 2021
pubmed: 25 2 2021
medline: 18 5 2021
entrez: 24 2 2021
Statut: ppublish

Résumé

Patients with inflammatory arthritis represent a possible high-risk group to COVID-19 due to their immunosuppressive regimen designed to maintain low disease activity. Thus, substantial effort has been put forth to understand the impact of COVID-19 on these patients. Patients with rheumatic diseases as a whole do not appear to be more susceptible to acquiring COVID-19. Furthermore, immunosuppression generally did not increase the likelihood of developing severe COVID-19, with the important exception of medium and high-dose glucocorticoid use. In addition, a small number of COVID-19 patients have developed new inflammatory arthritis; whether this represents an unmasking of previous subclinical disease or a bone fide virus-induced arthritis is unclear. Nevertheless, it appears that inflammatory arthritis patients currently on immunosuppression should continue their medication to prevent future flares and limit glucocorticoid usage. While this continues to be a rapidly evolving field, these data are reassuring to both patients with and providers treating inflammatory arthritides.

Identifiants

pubmed: 33626415
pii: S1931-5244(21)00047-5
doi: 10.1016/j.trsl.2021.02.010
pmc: PMC7897406
pii:
doi:

Substances chimiques

Immunosuppressive Agents 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

49-59

Subventions

Organisme : Medical Research Council
ID : MR/P028071/1
Pays : United Kingdom
Organisme : NIAMS NIH HHS
ID : T32 AR048522
Pays : United States

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Références

J Rheumatol. 2020 Oct 1;47(10):1593-1595
pubmed: 32611670
Arthritis Rheumatol. 2020 Dec;72(12):1981-1989
pubmed: 32725762
Arthritis Rheumatol. 2020 Sep;72(9):e1-e12
pubmed: 32734689
Arthritis Res Ther. 2019 Aug 30;21(1):199
pubmed: 31470887
Arthritis Rheum. 2000 Feb;43(2):365-9
pubmed: 10693876
Br Med J (Clin Res Ed). 1987 Feb 21;294(6570):484
pubmed: 3103739
J Clin Rheumatol. 2020 Sep;26(6):233
pubmed: 32694352
Ann Rheum Dis. 2021 Feb;80(2):1-2
pubmed: 32586918
Autoimmun Rev. 2020 Jul;19(7):102575
pubmed: 32376395
JAMA. 2020 Apr 21;323(15):1437-1438
pubmed: 32150622
Best Pract Res Clin Rheumatol. 2021 Mar;35(1):101661
pubmed: 33526325
Autoimmun Rev. 2020 Jul;19(7):102568
pubmed: 32376398
Lancet Rheumatol. 2020 Sep;2(9):e518-e519
pubmed: 32838313
Ann Rheum Dis. 2021 Apr;80(4):e58
pubmed: 32471899
Clin Rheumatol. 2004 Feb;23(1):59-62
pubmed: 14749987
JCI Insight. 2020 Aug 6;5(15):
pubmed: 32554923
Ann Rheum Dis. 2021 Apr;80(4):e52
pubmed: 32616604
Rheumatology (Oxford). 2017 Oct 1;56(10):1648-1661
pubmed: 28013196
Lancet Public Health. 2020 May;5(5):e279-e288
pubmed: 32311320
Cureus. 2020 Aug 12;12(8):e9698
pubmed: 32923288
Ann Rheum Dis. 2021 May;80(5):e67
pubmed: 32591357
Arthritis Rheumatol. 2020 Oct;72(10):1600-1606
pubmed: 32506699
Ann Rheum Dis. 2020 Jul;79(7):986-988
pubmed: 32467245
Arthritis Rheumatol. 2015 Jun;67(6):1577-85
pubmed: 25772621
Arthritis Rheum. 2002 Sep;46(9):2287-93
pubmed: 12355475
Ann Rheum Dis. 2011 May;70(5):785-91
pubmed: 21288960
Clin Exp Immunol. 2020 Nov;202(2):149-161
pubmed: 32671831
Ann Rheum Dis. 2020 Aug 19;:
pubmed: 32816697
ACR Open Rheumatol. 2020 Jun;2(6):335-343
pubmed: 32311836
N Engl J Med. 2020 Jul 23;383(4):393-395
pubmed: 32598829
Lancet Rheumatol. 2020 Nov;2(11):e655-e657
pubmed: 33043303
Ann Rheum Dis. 2021 Jun;80(6):e85
pubmed: 32576568
Ann Rheum Dis. 2020 Jul;79(7):851-858
pubmed: 32503854
Ann Rheum Dis. 2020 Sep;79(9):1156-1162
pubmed: 32457048
Ann Rheum Dis. 2022 Oct;81(10):e190
pubmed: 32759256
J Bone Joint Surg Am. 2020 Jul 15;102(14):1197-1204
pubmed: 32675661
Lancet Rheumatol. 2020 Sep;2(9):e549-e556
pubmed: 32838307
Ann Rheum Dis. 2020 Aug;79(8):1007-1013
pubmed: 32444415
Ann Rheum Dis. 2020 Aug 4;:
pubmed: 32753423
RMD Open. 2020 Aug;6(2):
pubmed: 32763956
J Orthop Surg Res. 2020 May 18;15(1):178
pubmed: 32423471
Arthritis Rheum. 2002 Sep;46(9):2294-300
pubmed: 12355476
Ann Rheum Dis. 2023 Feb;82(2):e38
pubmed: 32632035
Nature. 2020 Aug;584(7821):430-436
pubmed: 32640463
Ann Rheum Dis. 2020 Sep;79(9):1163-1169
pubmed: 32546598
Nat Rev Rheumatol. 2020 Aug;16(8):465-470
pubmed: 32561873
Ann Rheum Dis. 2021 Mar;80(3):e35
pubmed: 32475835
Ann Rheum Dis. 2022 Dec;81(12):e245
pubmed: 32769151
Arthritis Rheum. 1985 Jan;28(1):98-9
pubmed: 3966942
Ann Rheum Dis. 2020 Sep;79(9):1170-1173
pubmed: 32532753
Ann Rheum Dis. 2022 Oct;81(10):e189
pubmed: 32732243
Clin Pharmacol Ther. 2020 Aug;108(2):182-184
pubmed: 32311763
Ann Rheum Dis. 2020 May;79(5):667-668
pubmed: 32241793
Semin Arthritis Rheum. 2020 Oct;50(5):885-889
pubmed: 32896705
J Proteome Res. 2020 Nov 6;19(11):4417-4427
pubmed: 32786691
Ann Rheum Dis. 2020 Dec;79(12):1544-1549
pubmed: 32796045
JAMA Netw Open. 2020 May 1;3(5):e209759
pubmed: 32442288
Arthritis Rheumatol. 2020 Jan;72(1):114-124
pubmed: 31353826
Int J Rheum Dis. 2020 Nov;23(11):1541-1549
pubmed: 32940963
Ann Rheum Dis. 2020 Jun;79(6):737-739
pubmed: 32295789
Lancet Child Adolesc Health. 2020 Oct;4(10):e38
pubmed: 32835654
Arthritis Rheum. 1977 Mar;20(2):647-52
pubmed: 849359
Tohoku J Exp Med. 2020;251(2):87-90
pubmed: 32536670
J Clin Invest. 1975 May;55(5):930-6
pubmed: 1123429
Ann Rheum Dis. 2020 Jul;79(7):859-866
pubmed: 32471903
Ann Rheum Dis. 1999 Mar;58(3):175-81
pubmed: 10364916
J Thromb Haemost. 2015 May;13(5):732-42
pubmed: 25418346
Semin Arthritis Rheum. 2020 Aug;50(4):564-570
pubmed: 32425260
N Engl J Med. 2020 Jul 2;383(1):85-88
pubmed: 32348641
Transl Res. 2020 Jun;220:1-13
pubmed: 32299776
Lancet Respir Med. 2020 Dec;8(12):1167-1168
pubmed: 33007240
Clin Med (Lond). 2020 May 5;20(3):256-261
pubmed: 32371418
Joint Bone Spine. 2020 Oct;87(5):439-443
pubmed: 32445935
Clin Exp Immunol. 1988 Sep;73(3):473-8
pubmed: 3208454
Lancet. 2015 Jul 18;386(9990):258-65
pubmed: 25975452
Ann Rheum Dis. 2021 Jun;80(6):e91
pubmed: 32632032
Arthritis Res Ther. 2009;11(4):R109
pubmed: 19604357
Ann Rheum Dis. 2020 Sep;79(9):1143-1151
pubmed: 32719045
Ann Rheum Dis. 2021 Mar;80(3):e37
pubmed: 32503849
Ann Rheum Dis. 2021 Jun;80(6):e93
pubmed: 32719041
Ann Rheum Dis. 2021 Jun;80(6):e101
pubmed: 32591356
N Engl J Med. 2020 Dec 3;383(23):2291-2293
pubmed: 33176080
J Med Virol. 2021 Jan;93(1):192-193
pubmed: 32652541
J Immunol. 2010 May 15;184(10):5914-27
pubmed: 20404278
Front Immunol. 2018 May 28;9:1057
pubmed: 29892280
Ann Rheum Dis. 2021 Mar;80(3):e44
pubmed: 32493726
Lancet Rheumatol. 2020 Jun;2(6):e325-e331
pubmed: 32501454
Ann Rheum Dis. 2020 Nov;79(11):1393-1399
pubmed: 32769150
Clin Exp Rheumatol. 1983 Oct-Dec;1(4):287-93
pubmed: 6398166
Arthroscopy. 1997 Dec;13(6):739-42
pubmed: 9442328

Auteurs

Richard Conway (R)

Department of Rheumatology, St. James's Hospital, Dublin, Ireland.

Maximilian F Konig (MF)

Division of Rheumatology, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland.

Elizabeth R Graef (ER)

The COVID-19 Global Rheumatology Alliance, Boston, Massachusetts.

Kate Webb (K)

Division of Paediatric Rheumatology, School of Child and Adolescent Health, Red Cross War Memorial Children's Hospital, University of Cape Town, Cape Town, South Africa; Crick African Network, Francis Crick Institute, London, UK.

Jinoos Yazdany (J)

Division of Rheumatology, Department of Medicine, Zuckerberg San Francisco General Hospital, University of California, San Francisco, California. Electronic address: Jinoos.Yazdany@ucsf.edu.

Alfred H J Kim (AHJ)

Division of Rheumatology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri. Electronic address: akim@wustl.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH